Sovilnesib

Sovilnesib · Volastra Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Sovilnesib, covering 2025-10-20 to 2025-10-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Sovilnesib in Subjects With Ovarian Cancer [Phase 1]